Upgrade to SI Premium - Free Trial

Raymond James Reiterates Strong Buy Rating on Vir Biotechnology (VIR)

September 28, 2026 2:03 PM
Raymond James analyst Sean McCutcheon reiterated a Strong Buy rating and $19.00 price target on Vir Biotechnology (NASDAQ: VIR).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments